SCHEMBL6000944

SCHEMBL6000944

CO[C](OCc1ccccc1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
KMT2A Q03164 3/20 0.55
TDP1 Q9NUW8 2/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A3 Q01959 1/20 0.55
RAB9A P51151 4/20 0.46
LMNA P02545 4/20 0.46
NPC1 O15118 2/20 0.46
MAPK1 P28482 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 2/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3726778 0.87 TDP1 (0.63) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL10447267 0.79 LTA4H (0.53) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL93631 0.78 TSHR (0.56) ALDH1A1KMT2ATDP1SLC6A3RAB9A
SCHEMBL992319 0.77 ALDH1A1 (0.57) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL28683220 0.76 KMT2A (0.50) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL15094083 0.75 ALDH1A1 (0.61) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL2701981 0.75 ALDH1A1 (0.61) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
Formaldehyde SCHEMBL28519005 0.74 ALDH1A1 (0.60) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL11268071 0.74 TDP1 (0.63) ALDH1A1KMT2ATDP1SLC6A2SLC6A3
SCHEMBL11229650 0.73 ALDH1A1 (0.53) ALDH1A1KMT2ATDP1SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed